GSK256073
GSK256073 is a potent, orally bioavailable, and non-flushing full agonist of the hydroxy-carboxylic acid receptor 2 (HCA2/GPR109A) . It acutely improves glucose homeostasis by inhibiting lipolysis, making it a valuable research tool for studying metabolic disorders such as type 2 diabetes and dyslipidemia in both in vitro and in vivo models.
Product Specifications
CAS Number
862892-90-8
Product Name Alternative
Inhibit, Inhibitor, GPR109A, GPR109A (G-protein coupled receptor 109A), glucose, GSK 256073, GSK256073, GSK-256073, GPCR, HCAR2, HCA2, HCA2 (hydroxy-carboxylic acid receptor 2), HM74A, mellitus, homeostasis, dyslipidaemia, diabete, PUMA-G, type 2, T2DM
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.03% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:1.5 mg/mL (5.84 mM) ; DMSO:16.67 mg/mL (64.94 mM)
Smiles
CCCCCn1c2nc (Cl) [nH]c2c (=O) [nH]c1=O
Molecular Formula
C10H13ClN4O2
Molecular Weight
256.69
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP721546M 100 µg
ACM4 Human Recombinant Protein, Synthetic Nanodisc
Sign In for Pricing
View Details 
GTR10396537 96 Well
Monkey Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (ATP2A1) ELISA kit
Sign In for Pricing
View Details